This opinion piece was written by Calvin Rasode, Vice President, Marketing, Brains Bioceutical When Donald Trump tweets, the world pays
Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and
The European cannabis events season is now in full swing, and this month all eyes are turning to Switzerland, one
Breaking New Ground in Cannabinoid Research: Brains Bioceutical Corp’s Solid THC Paves the Way for Revolutionary Drug Development for the
The sixth annual Cannabis Invest UK conference took place in the heart of London last week, bringing together cannabis business,
We won’t spam you
